Literature DB >> 26685390

Meeting of the Strategic Advisory Group of Experts on immunization, October 2015 – conclusions and recommendations.

.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26685390

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN: 0049-8114


× No keyword cloud information.
  24 in total

1.  Systems analysis of protective immune responses to RTS,S malaria vaccination in humans.

Authors:  Dmitri Kazmin; Helder I Nakaya; Eva K Lee; Matthew J Johnson; Robbert van der Most; Robert A van den Berg; W Ripley Ballou; Erik Jongert; Ulrike Wille-Reece; Christian Ockenhouse; Alan Aderem; Daniel E Zak; Jerald Sadoff; Jenny Hendriks; Jens Wrammert; Rafi Ahmed; Bali Pulendran
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-13       Impact factor: 11.205

2.  Rapid Establishment of a Cold Chain Capacity of -60°C or Colder for the STRIVE Ebola Vaccine Trial During the Ebola Outbreak in Sierra Leone.

Authors:  Morrison O Jusu; Geoffrey Glauser; Jane F Seward; Mohamed Bawoh; Judith Tempel; Michael Friend; Daniel Littlefield; Michael Lahai; Hassan M Jalloh; Amara Bangali Sesay; Amanda F Caulker; Mohamed Samai; Vasavi Thomas; Nicholas Farrell; Marc-Alain Widdowson
Journal:  J Infect Dis       Date:  2018-05-18       Impact factor: 5.226

3.  The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak.

Authors:  Mohamed Samai; Jane F Seward; Susan T Goldstein; Barbara E Mahon; Durodami Radcliffe Lisk; Marc-Alain Widdowson; Mohamed I Jalloh; Stephanie J Schrag; Ayesha Idriss; Rosalind J Carter; Peter Dawson; S A S Kargbo; Bailah Leigh; Mohamed Bawoh; Jennifer Legardy-Williams; Gibrilla Deen; Wendy Carr; Amy Callis; Robert Lindblad; James B W Russell; Carey R Petrie; Augustin E Fombah; Brima Kargbo; Wendi McDonald; Olamide D Jarrett; Robert E Walker; Paul Gargiullo; Donald Bash-Taqi; Laura Gibson; Abu Bakarr Fofanah; Anne Schuchat
Journal:  J Infect Dis       Date:  2018-05-18       Impact factor: 5.226

4.  Measles and Rubella Seroprevalence Among HIV-infected and Uninfected Zambian Youth.

Authors:  Catherine G Sutcliffe; Kelly Searle; Hellen K Matakala; Michelle P Greenman; Kaitlin Rainwater-Lovett; Philip E Thuma; William J Moss
Journal:  Pediatr Infect Dis J       Date:  2017-03       Impact factor: 2.129

Review 5.  Measles, the need for a paradigm shift.

Authors:  Emilie Javelle; Philippe Colson; Philippe Parola; Didier Raoult
Journal:  Eur J Epidemiol       Date:  2019-10-17       Impact factor: 8.082

Review 6.  Considerations for use of Ebola vaccine during an emergency response.

Authors:  Jenny A Walldorf; Emily A Cloessner; Terri B Hyde; Adam MacNeil
Journal:  Vaccine       Date:  2017-09-07       Impact factor: 3.641

7.  Global Transmission of Live Polioviruses: Updated Dynamic Modeling of the Polio Endgame.

Authors:  Dominika A Kalkowska; Mark A Pallansch; Steven G F Wassilak; Stephen L Cochi; Kimberly M Thompson
Journal:  Risk Anal       Date:  2020-01-20       Impact factor: 4.000

8.  Risk factors for measles infection in 0-7 month old children in China after the 2010 nationwide measles campaign: A multi-site case-control study, 2012-2013.

Authors:  Chao Ma; Christopher J Gregory; Lixin Hao; Kathleen A Wannemuehler; Qiru Su; Zhijie An; Linda Quick; Lance Rodewald; Fubao Ma; Rui Yan; Lizhi Song; Yanyang Zhang; Yi Kong; Xiaoshu Zhang; Huaqing Wang; Li Li; Lisa Cairns; Ning Wang; Huiming Luo
Journal:  Vaccine       Date:  2016-03-21       Impact factor: 3.641

Review 9.  On a path to accelerate access to Ebola vaccines: The WHO's research and development efforts during the 2014-2016 Ebola epidemic in West Africa.

Authors:  Ana Maria Henao-Restrepo; Marie-Pierre Preziosi; David Wood; Vasee Moorthy; Marie Paule Kieny
Journal:  Curr Opin Virol       Date:  2016-05-12       Impact factor: 7.090

Review 10.  Eradication of measles: remaining challenges.

Authors:  Heidemarie Holzmann; Hartmut Hengel; Matthias Tenbusch; H W Doerr
Journal:  Med Microbiol Immunol       Date:  2016-03-02       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.